Background. Health economic evaluations frequently include projections for lifetime costs and health effects using modeling frameworks such as Markov modeling or discrete event simulation (DES). Markov models typically cannot represent events whose risk is determined by the length of time spent in state (sojourn time) without the use of tunnel states. DES is very flexible but introduces Monte Carlo variation, which can significantly limit the complexity of model analyses. Methods. We present a new methodological framework for health economic modeling that is based on, and extends, the concept of moment-generating functions (MGFs) for time-to-event random variables. When future costs and health effects are discounted, MGFs can be used to very efficiently calculate the total discounted life-years spent in a series of health states. Competing risks are incorporated into the method. This method can also be used to calculate discounted costs and health effects when these payoffs are constant per unit time, oneoff, or exponential with regard to time. MGFs are extended to additionally support costs and health effects which are polynomial with regard to time (as in a commonly used model of population norms for EQ-5D utility). Worked Example. A worked example is used to demonstrate the application of the new method in practice and to compare it with Markov modeling and DES. Results are compared in terms of convergence and accuracy, and computation times are compared. R code and an Excel workbook are provided. Conclusions. The MGF method can be applied to health economic evaluations in the place of Markov modeling or DES and has certain advantages over both.
Mathematical models are frequently used in health economic evaluations to extrapolate beyond observed data for estimates of lifetime costs and effects. 1 The observed data may come from experimental trials as well as from observational sources, such as registries. 2 Often, the effects of interventions are measured in life-years or quality-adjusted life-years (QALYs), as particularly the latter allows for comparisons of cost-effectiveness across different interventions, populations, and diseases. 3 As spending and health effects usually do not happen simultaneously, there is a need to consider the time preferences for costs and effects. It is near universal practice to use a constant rate of discounting 4 (e.g., 3 .5% for evaluations following the National Institute for Health and Care Excellence reference case 5 ).
A very common approach in modeling is to represent the health status of any given individual using one of a finite set of mutually exclusive health states. 6 The individual may transition between these states as aspects of their health status or care provision change. Such models Health Economics Group, University of Exeter, Exeter, UK (TS). The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. The author received no financial support for the research, authorship, and/or publication of this article. are termed state transition models. For example, in a model of treatments for renal failure, there may be separate health states for patients with a kidney transplant, patients receiving hemodialysis, patients receiving peritoneal dialysis, and patients who have died. Health states are associated with probabilities/rates/time-to-event (TTE) distributions of transitions to other health states as well as payoffs (typically costs and health state utility values). The most common implementations of state transition models are Markov models (cohort simulation and microsimulation) and discrete event simulation (DES). Another modeling method, partitioned survival analysis, resembles Markov cohort simulation, but transitions are not modeled; rather, the state membership over time is explicitly modeled according to a set of survival curves. 7 The cohort-based methods are generally very computationally tractable but lack flexibility, while the simulation-based methods are highly flexible but introduce Monte Carlo variation. Monte Carlo variation can be minimized by producing large numbers of simulations, but this can be computationally costly, and even when minimized, Monte Carlo variation can represent a challenge for model verification.
Probabilistic sensitivity analysis is frequently used to estimate the joint impact of uncertainty across all parameters and requires an extra ''loop'' of calculations to explore the joint parameter space. 8 Traditional partial expected value of perfect information (pEVPI) analyses require an additional loop, which means a 3-level loop in the case of a patientlevel simulation model, and model calibration exercises require repeated evaluation of expected outputs from a model, creating a similar computational challenge (many numerical methods for optimization require estimates of the partial derivative of the function with respect to the parameter space, which cannot be accurately estimated in the presence of random noise). While some advances have been made to avoid the additional loop for pEVPI, 9 it remains true that, in general, an analyst would prefer to obtain model outputs for a given set of input parameters that are unaffected by Monte Carlo variation.
This article sets out a method that can be used to compute expected life-years, lifetime costs, and QALYs when there is discounting. The method uses and extends moment-generating functions (MGFs). By virtue of considering state transition models in which the times to transition are modeled (as opposed to probabilities or rates) and using MGFs, the method shares many principles with statistical flowgraph modeling, 10 which explicitly describes processes in terms of branch probabilities (such as a decision tree or Markov model) and MGFs for waiting time distributions. The method in this article does not rely on statistical flowgraph modeling techniques but instead is optimized to consider cumulative discounted costs and outcomes, as these are of interest in health economic applications.
The substantial advantage of the method described in this article over Markov cohort simulation is the ability to model transitions, costs, and QALY weights, which are dependent on the length of time spent in a particular state (i.e., it overcomes the Markov memoryless property). Individual patient simulation methods (e.g., Markov microsimulation and DES) are not restricted by the Markov memoryless property, but they introduce Monte Carlo variation, with the challenges outlined above. The method set out in this article achieves greater flexibility over Markov cohort simulation while still producing deterministic results.
Methods
This section begins with a description of MGFs and a simple motivating example for why MGFs arise naturally when considering discounted outcomes in models. An introduction to statistical flowgraph models is provided next, followed by a description of how the methods applied in the motivating example can be extended to consider not just discounted life-years but also discounted costs and QALYs when the rates at which these are accrued vary according to state, time within state, and time since the model origin. We next consider alternative competing risk formulations besides the one assumed in statistical flowgraph modeling. The section concludes with notes on calculating MGFs in practice and an overall summary of the method.
MGFs
The MGF, M X t ð Þ, of a random variable, X , is defined as
For example, the MGF of an exponentially distributed random variable, X ; Exp l ð Þ is l= l À t ð Þ as shown below:
The final step of this derivation can be derived through usual means or by recognizing that the integrand is the probability density function for an exponential random variable with rate l À t, and so the integral across all its domain must equal 1.
Discounting
As noted in the introduction, it is near universal practice to use a constant rate of discounting. This is often presented as an annual discount rate, such that the discounted value of a cost C incurred X years in the future is
where r a is the annual discount rate (e.g., 0.035) for a discount rate of 3.5% per year. It is more mathematically convenient to use a continuous discounting formula that is equivalent:
where r is the continuous discount rate. These discount rates are readily calculated from each other:
Throughout this article, we use the continuous discounting formula. Note that if X , the time at which the cost is incurred, is a random variable, we can take the expectation of the discounted cost and then express it in terms of the MGF of X :
This is indeed the fundamental observation underpinning the method outlined in this article: that quantities in a health economic evaluation with discounting can be expressed in terms of MGFs.
Motivating Example Part 1. Consider a very simple 2-state model in which patients are either alive or dead, and the hazard rate of death is a constant (l); that is, the TTE distribution for death is an exponential distribution. If we let X denote the time to death, then f X x ð Þ and F X x ð Þ are the probability density and cumulative distribution functions, respectively:
The life-years lived (for a particular value of X ) is simply
that is, life-years lived is a random variable (or a function of a random variable). Given this, life expectancy is
Now consider discounted life-years lived using the continuous discounting function given in equation 4:
This is also a (function of a) random variable, and its expectation can be obtained:
The quantity E X e ÀrX ½ is equal to the MGF of X , M X t ð Þ ¼ def E X e tX ½ , evaluated at t = Àr. For the exponential distribution, the MGF was shown above to be
So we can substitute this into equation 12:
Note that we have not considered any transition probabilities (as in a discrete-time Markov model) or rates (as in a continuous-time Markov model) but only TTE variables (as in a DES).
Part 2. Now we consider a slightly more complex model in which there are 3 states: healthy, diseased, and dead. We assume that transitions are possible between healthy and diseased and between diseased and dead (i.e., we do not include recovery from disease or death from other causes). Let X 1 denote the TTE variable for transitioning from healthy to diseased, and let X 2 denote the TTE variable for transitioning from diseased to dead. Assume X 1 and X 2 are independent. Life-years lived is then
Life expectancy is calculated simply as:
Discounted life-years are calculated as:
and discounted life expectancy is:
This illustrates a key property of MGFs, that the MGF of the sum of 2 independent random variables is the product of their MGFs. It also illustrates that it is necessary to evaluate the MGFs only at single points. In Supplementary Appendix 1, we demonstrate that the method applied above, with exponential TTE distributions, gives identical results to an equivalent Markov cohort simulation (in the limit as the cycle length tends to zero) and to direct calculation of the state occupancy equations.
Exponential TTE distributions are easy to work with in most contexts, but the MGF method described in this article can be applied with any distribution with a finite MGF at the necessary points.
Statistical Flowgraph Models
Statistical flowgraph models 10 are a type of state transition model that can be understood in a similar manner to discrete-time Markov models, in that from any state, there is a probability of transitioning to another state or remaining in the current state. The key point of divergence from Markov models is that the time steps are not of fixed length but are random TTE variables.
Although developed independently of statistical flowgraph models, there are similarities between the method proposed in this article and statistical flowgraph models, so it is instructive to introduce them as an area for potential cross-fertilization and to highlight differences for readers who may already be familiar with them.
Statistical flowgraph models have seen use in engineering applications and have also been applied to health but have not seen notable use in health economic modeling. Their focus is typically on deriving an overall MGF for a waiting time distribution of interest (e.g., survival distribution) and then ''inverting'' this into a probability density function. 10 Note that this is different from the approach described in this article, in which the MGF itself is evaluated and used within expressions to derive discounted outcomes.
Statistical flowgraph models are stochastic multistate models represented by directed graphs in which nodes represent states and edges represent transitions between those states (i.e., events). Each edge has a transmittance, which is the product of a transition probability and an MGF. The transition probability represents the probability that a modeled item (e.g., an individual) will transition along that edge (i.e., experience the given event) as opposed to any alternative edge from the current node. The MGF describes the TTE variable for how long the item waits in the state before transitioning along the edge, conditional on the item transitioning along that edge. Figure 1 presents an example statistical flowgraph model with 3 states labeled 1, 2, and 3. These could, respectively, represent healthy, diseased, and dead in a health economic model where it is possible to recover from disease and to die while healthy or diseased. The transmittance labels are such that p ij is the transition probability of transitioning from state i to state j and M ij t ð Þ is the MGF for the waiting time in state i prior to transition to state j.
In such an example, we are likely interested to know the distribution of time spent prior to reaching state 3, given an item starts in state 1 (or 2). There are manual reduction procedures for solving a statistical flowgraph model (determining the MGF for a waiting time of interest), as well as a procedure based on linear algebra, Mason's rule. 11 If we are interested in finding the MGF for the waiting time distribution from state 1 to state 3, we will eventually identify that
At this stage, an analyst would typically use numerical methods to invert the MGF into a probability density function for the waiting time distribution; however, if we are interested in the expected discounted life-years from state 1 to state 3, we can simply employ the approach we have used before: 
where M Á ð Þ is the MGF for the solved flowgraph model.
Beyond Discounted Life-Years
In many health economic evaluations, we are interested to know the (incremental) discounted costs and QALYs associated with an intervention. Costs and QALYs (or other ''payoffs'' of interest) are typically not accrued at a constant rate but vary according to the health state of an individual, how long the individual has been in a health state, and how old the individual is. Consider a simple model of renal failure, as shown in Figure 2 . Individuals start the model with end-stage renal failure and in receipt of dialysis, which has significant ongoing costs and poor quality of life. Some individuals receive a transplant, which has a significant upfront cost and some ongoing costs, a better quality of life than dialysis, and better life expectancy. Let c 1 and u 1 denote the cost rate and QALY weight in dialysis, let c 12 denote the cost of transplantation, and c 2 and u 2 the cost rate and QALY weight for transplanted patients. For now, assume no cost of death and that cost rates and QALY weights are constant within each state.
Since there are no cycles, it is easy to deduce that there are 2 paths to death: dialysis ! transplant ! death (with probability p 12 ) and dialysis ! death (with probability p 13 = 1 À p 12 ).
If the patient dies without transplantation, they live for X 13 years, accruing costs at a rate of c 1 and QALYs at a rate of u 1 . Their discounted costs and QALYs can be written as a function of X 13 : 
The expectation of these is taken by replacing e ÀrX 13 with E X 13 e ÀrX 13 ½ = M X 13 Àr ð Þ. If, instead, the patient is transplanted, they live on dialysis for X 12 years and then with a transplant for X 23 years. The cost of their transplantation is incurred at time X 12 and is therefore expected to be discounted by E X 12 e ÀrX 12 ½ = M X 12 Àr ð Þ. The discounted costs and QALYs accrued posttransplantation are
Once again, the expectation is taken by replacing e ÀrX 12 with E X 12 e ÀrX 12 ½ = M X 12 Àr ð Þ and also replacing e Àr X 12 + X 23 ð Þ with E X 12 , X 23 e Àr X 12 + X 23 ð Þ Â Ã = M X 12 Àr ð ÞM X 23 Àr ð Þ. In total, therefore, we have the following lifetime expected discounted costs and QALYs:
In addition to one-off payoffs (e.g., the cost of transplantation above) and constant per-state payoffs (e.g., the QALY weight in dialysis above), we can quite easily incorporate payoff functions that include exponential functions of time.
For example, if the QALY weight following surgery is initially low but soon improves to a higher baseline, we may use a utility function u x ð Þ = u h À u h À u l ð Þe Àax , where u l and u h are the low and high QALY weights and a is a parameter that determines how quickly QALY weights recover. In this example, x would represent time since surgery (i.e., time in a postsurgery state), so expected discounted QALYs could be (assuming we are considering QALYs accrued in a state entered at time X 12 and exited at time X 12 + X 23 ) as follows: 
Extended moment-generating functions and polynomial payoffs. We may also want to incorporate polynomial functions for payoffs. A common example would be to have baseline QALY weights be a polynomial function of age, for example, the quadratic model for population norms of EQ-5D utility described by Ara and Brazier. 12 Attempting to employ the method described so far in the case of polynomial payoffs, after repeated application of integration by parts, results in terms that are the product of a power and exponential function of a random variable, that is, X j e ÀrX . The expectation of this is not E X j ½ E e ÀrX ½ , since these 2 components are not independent. Instead, we newly define the extended momentgenerating function (EMGF) as
and derive the following property of the EMGF: If S = P i a i X i is a linear combination of independent random variables, and n is a nonnegative integer, then
This summation is conducted over all possible combinations of nonnegative integer k i where they sum to n. This means the EMGF for a linear combination of independent random variables can be written as a linear combination of their EMGFs.
Consider an example in which the health state utility value declines linearly once in a state:
By combining constant, one-off, exponential, and polynomial payoffs, we can define models with significant flexibility that would not be possible in traditional Markov cohort simulations.
Flowgraph Cycles
In the previous example ( Figure 2) , there were no cycles (''cycles'' is used here in the graph theoretical sense, i.e., paths in the flowgraph that return to a previously visited state, in contrast to time cycles as used in discrete Markov models). We might consider this unrealistic and want to include failure of a kidney graft, after which patients return to dialysis. To incorporate this, we could add another edge to our model with a transmittance of p 21 Á M 21 t ð Þ. The transmittance for the edge denoting death with a kidney transplant would change to p 23 Á M 0 23 t ð Þ (we use M 0 23 t ð Þ since the conditional TTE distribution may change after introducing a new competing risk). Patients can now in theory cycle infinitely many times between dialysis and a kidney transplant before dying, but in practice, a geometric limit applies. In Supplementary Appendix 2, we go through the necessary steps to produce a formula for the discounted life-years lived in dialysis. There is no reason why similar steps cannot be taken to calculate other discounted payoffs.
We note, however, that the mathematics are quite involved and that it is likely that little is gained from having a model with a cycle versus a model in which there is a finite number of retransplantations allowed (indeed, this could be made more realistic than the model with cycles since the probability of obtaining a second or third transplant is likely different from the probability of obtaining an initial transplant).
Cycles should be incorporated into a model only where it is realistic to believe patients could cycle many times and that the parameters governing the transitions would not change with the number of cycles completed.
Alternative Competing Risk Formulations
So far, we have considered the competing risk formulation used in statistical flowgraph modeling, which has also been described as the pattern mixture approach to competing risks. 13 In this formulation, we use transition probabilities to determine which event takes place (i.e., a categorical distribution), and then a TTE distribution is defined (by its MGF) for the waiting time prior to that event. Alternative competing risk formulations have been used in data modeling and in simulations.
A simple (although not as flexible) alternative is to model event times as latent independent event times, and the earliest of these is the event that takes place (with the corresponding event time). This is a very typical approach in DESs. 14 These event times can be sampled according to shared covariates to account for population heterogeneity. For example, in a renal failure model, we could model time to death on dialysis and time to transplantation as dependent on age (younger patients are sometimes prioritized for transplants but also have a higher life expectancy on dialysis). This approach is particularly desirable when producing a health economic model from aggregate data from multiple data sources. The approach is readily incorporated into the framework described in this article since it is not computationally difficult to convert this competing risks formulation into the pattern mixture formulation. Further details are provided in Supplementary Appendix 3.
Other notable frameworks are the Fine and Gray method of competing risk subhazard distributions 15 and the vertical modeling approach. 16 These have not yet been incorporated into the framework described in this article.
Methods for Evaluating MGFs
Some probability distributions used in economic modeling have MGFs with closed forms. We have already seen the MGF of the exponential distribution, and in Supplementary Appendix 4, we derive the MGFs and extended MGFs of the exponential, gamma, degenerate, and continuous uniform distributions. Other parametric survival distributions frequently used in health economic evaluations (e.g., Weibull, log-normal, generalized gamma) do not have finite closed-form MGFs.
Evaluating the MGF of a distribution at a particular value involves performing a single 1-dimensional integration with 1 improper limit (the lower limit is 0 because TTE distributions are nonnegative; the upper limit is infinite because a lifetime horizon is assumed), which is not challenging for modern statistical programs, as they can automatically perform appropriate transformations and apply Gaussian quadrature techniques (e.g., the integrate function in R). Spreadsheet software typically does not include such functionality, but the transformations and Gaussian quadrature can nevertheless be readily implemented provided the nodes and weights for Gaussian quadrature (constants) are calculated in a suitable package. For simplicity, the transformation
Þ, which is suitable for Gauss-Legendre quadrature (see Supplementary Appendix 5) .
We can also calculate the MGF for nonparametric TTE distributions, specifically Kaplan-Meier curves (see Supplementary Appendix 4 ). This can be very useful when observed survival is not well fitted by a parametric survival function.
Summary of the MGF Method
We now briefly summarize the procedure for conducting a model-based health economic evaluation using MGFs, the MGF method.
Step 1: Conceptualize the model in terms of health states and events. Following suitable methodology (e.g., Roberts et al. 17 ), identify health states and any events that need to be represented. Events typically lead to transitions between health states.
Step 2: Identify suitable waiting time distributions. Depending on data availability, waiting time distributions for events should preferably be identified using the pattern-mixture formulation as used in statistical flowgraph models. Failing this, independent TTE distributions should be identified for the events in the model.
Step 3: Identify suitable payoff functions. Costs and QALYs are accumulated in the model either at a constant rate (for each state), as a one-off (e.g., surgery cost), or with rates that are expressed in polynomial or exponential terms with regard to time (waiting time in the state or time since the start of the model). Linear combinations are also allowable. Suitable payoff functions should be identified, bearing in mind that polynomial functions will require calculations of EMGFs.
Step 4: Develop expressions for total discounted payoffs. Expressions for total discounted payoffs are developed in terms of (extended) MGFs.
Take each payoff in each state one at a time. Let S be the sum of the TTE variables for the events that resulted in reaching the current state and let X I be the TTE variable for the event that results in exiting the current state. Let x denote the time since the start of the model. The (undiscounted) payoff function identified in step 3 is now written as f x, S ð Þ, noting that time in the current state is x À S. To discount it, multiply by e Àrx . The discounted payoff accrued in the state is then found by algebraically integrating this discounted payoff function from S to S + X I . This produces the accrued payoff as a function of the random variables S and X I . The expectation is then taken, relying on E e ÀrS Â Ã = M S Àr ð Þ, which will be the products of the MGFs for the random TTE variables, which sum to S (assuming these are independent) and similar expressions based on the extended MGF.
Total discounted payoffs are obtained by combining all such expressions, weighted according to the probabilities of those payoffs being accrued.
Step 5: Evaluate numerically. (Extended) MGFs with closed forms should be evaluated algebraically, and numerical integration techniques should be used for MGFs without closed forms to produce numerical estimates of total discounted payoffs.
Example Application
We present a worked example of the application of the MGF method (in particular, steps 4 and 5 described above), with comparison to evaluation using a Markov cohort simulation (with tunnel states), Markov microsimulation, and DES. We include code listings in Supplementary Appendix 6 for all 4 methods in R version 3.5, 18 making use of the heemod package for the Markov modeling. 19 Furthermore, fully working code has been uploaded to GitHub for the MGF and DES methods (https://www.github.com/tristansnowsill/mgfexample/). We additionally provide an Excel 2013 (Microsoft Corporation; Redmond, WA) implementation of the MGF method using Gauss-Legendre quadrature throughout. 20 The example model includes 2 health states (stable disease and progressive disease) and the death state ( Figure 3) . The sojourn-dependent TTE distributions are X 1 (representing disease progression), X 2 (death from stable disease), and X 3 (postprogression survival). These are modeled by Weibull, Gompertz, and log-normal distributions, respectively. Note that in this model, these TTE distributions are assumed to be independent of each other, and we do not specify branch probabilities as would be typical in a statistical flowgraph model.
The model includes one-off costs for progression and for death and constant cost rates in the stable disease and progressive disease states. It also includes an agedependent baseline utility using a quadratic formula and constant utility multipliers for stable and progressive disease.
It should be noted that there is only one aspect of this model that cannot be represented faithfully in a Markov cohort simulation without tunnel states, which is the lognormal distribution for survival in the progressive disease state, so this is in no way a pathological example.
Methods
MGF method. In the model, there are 2 different paths that individuals can take. They either suffer from disease progression and then death or they die without disease progression. We let p denote the probability of the first path being taken.
With probability p, the following costs are incurred:
C I : A steady cost accrued prior to progression (between x = 0 and x = X 1 ) C II : A one-off cost at time of progression (at x = X 1 ) C III : A steady cost accrued following progression (between x = X 1 and x = X 1 + X 3 )
C IV : A one-off cost at time of death (at x = X 1 + X 3 )
Also with probability p, the following QALYs are accrued:
B I : QALYs accrued prior to progression (between x = 0 and x = X 1 ) B II : QALYs accrued following progression (between x = X 1 and x = X 1 + X 3 )
With probability 1 À p ð Þ, the following costs are incurred:
C V : A steady cost accrued prior to death (between x = 0 and x = X 2 ) C VI : A one-off cost at time of death (at x = X 2 ) Also with probability 1 À p ð Þ, the following QALYs are accrued:
B III : QALYs accrued prior to death (between x = 0 and x = X 2 )
We consider the costs first:
C II = c progression e ÀrX 1 ð32Þ
c progressive e Àrx dx = c progressive r e ÀrX 1 À e Àr X 1 + X 3 ð Þ ð33Þ
c stable e Àrx dx = c stable r 1 À e ÀrX 2 À Á ð35Þ
where c stable and c progressive are the cost rates in the stable and progressive disease states, c progression is the one-off cost associated with disease progression, and c death is the one-off cost associated with death. Next, we consider the QALYs, where the baseline agedependent utility is given by u x ð Þ = u 0 + u 1 x + u 2 x 2 and utility is scaled by v stable in the stable disease state and v progressive in the progressive disease state.
First, we solve a ''helper'' integral:
Now,
Before we take the expected values of these quantities using MGFs, we need to realize that there has been some abuse of notation: we have used X 1 and X 2 in our equations above, where in fact these should be X 1 j X 1 \X 2 ð Þ and X 2 j X 2 \X 1 ð Þ , since progression and death without progression are competing events. Following the methods in Supplementary Appendix 3, we find
We produce a table of extended MGFs evaluated at t = Àr for n = 0, 1, 2, as shown in Table 1 . The bottom row is formed from the rows above following equation 28.
We now have all the pieces we need to derive total expected discounted costs and QALYs:
By linearity of expectation, we can consider E C I ½ , E C II ½ , . . . and E B I ½ , . . . separately. For example,
Markov cohort simulation. For comparison, a discrete time Markov model was constructed using the heemod package in R with the use of tunnel states. Sojourn-dependent transition probabilities were estimated by calculating the cumulative hazards for competing risks at the start and end of the cycle and converting these into transition probabilities assuming constant competing hazard rates within each cycle. This is more accurate than, for example, applying transition probabilities estimated from hazard rates at the start, midpoint, or end of each cycle.
The implementation of tunnel states in heemod means that the transition probabilities in the end state of the tunnel are based on the maximum sojourn time covered by the tunnel states; that is, there is no attempt to fit the final transition probability to the behavior of the survival curve beyond the tunnel duration.
Cycle lengths of 1 to 12 months were explored as well as maximum sojourn cycle memory of 1 (no tunnel states), 2 (1 tunnel state), 4 (3 tunnel states, etc.), 8, 16, and 32 . The life table method of estimating state membership between cycles was used. 21 Markov microsimulation. Also for comparison, a discrete time Markov microsimulation was built in R using the vectorization approach described by Krijkamp et al. 22 Sojourn-dependent transition probabilities were calculated as for the Markov cohort simulation. A cycle length of 1 month was used. Costs and QALYs were calculated, assuming that transitions occur at the end of each cycle. No half-cycle correction was applied.
DES. As a final comparator, a DES model was constructed using efficient vectorized operations. Variance reduction was included by using common samples of X 2 and X 3 across the control and treatment arms.
Results
The MGF method gave consistent results with the DES (see Table 2 and Figure 4 ). It was very efficient, requiring only 17 one-dimensional numerical integrals to be evaluated through Gaussian quadrature.
Even with 100,000 simulations and reasonable variance reduction measures, the DES still produced a somewhat imprecise estimate of economic value.
The Markov cohort simulation approach was able to reach a fair approximation of the true results when a large number of tunnel states was used and a short cycle length was employed (see Table 2 and Figure 5 ), but the approximation was poor when a longer cycle length was used and/or no/few tunnel states were employed. There is a tradeoff that as the cycle length is reduced, more tunnel states are required to represent the same portion of the survival curve.
Execution time. Execution time was measured using the microbenchmark package, with 100 replications on a laptop running R v3.5.1 (R Foundation for Statistical Computing) using RStudio v1.2 (RStudio, Inc.). The laptop was running Windows 7 (Microsoft Corporation) with an Intel Core i7 processor running at 2.6 GHz and with 16 GB RAM.
As shown in Table 3 , the MGF method is faster than the other methods, even being comparable to DES with a low number of simulations (1000). With 1000 simulations, DES retained a Monte Carlo standard error of 12.7% of incremental net monetary benefit. 
Discussion
We have presented the MGF method, a new method for calculating lifetime discounted costs and outcomes for health economic models, which is distinct from Markov modeling and DES and has advantages over both paradigms (see Table 4 and Supplementary Appendix 7 for a detailed comparison). It can represent sojourn-dependent transition times and payoffs in a very computationally tractable manner, in contrast to Markov modeling. It provides precision with fast convergence and no Monte Carlo variation, in contrast to DES. The ability to provide precise answers quickly also makes the MGF method well suited to analyses that are challenging when using DES, such as value of information analyses and Figure 4 Simulation results: (a) discrete event simulation (DES) and (b) Markov microsimulation. Points are individual simulation samples, the solid line is the cumulative mean incremental net monetary benefit, the shaded ribbon is the cumulative 95% confidence interval based on 1-sample t statistic, and the dashed line is the mean incremental net monetary benefit as calculated by the moment-generating function method. model calibration. In terms of how it fits in with an analyst's ''workflow,'' the closest analogy is a Markov cohort simulation: there is no need to produce multiple iterations to obtain an answer for a single set of parameters, but when conducting sensitivity analyses (including probabilistic sensitivity analysis), it is necessary to rerun the model using the different sets of parameters.
The MGF method can be readily implemented in specialist statistical packages such as R and Stata, as well as in widely available spreadsheet software such as Excel (without the use of VBA code). There is no reason to think it could not also be incorporated into specialist modeling software such as TreeAge. Future work may include procedural generation of code for the MGF Figure 5 Comparison of Markov models with different cycle lengths and numbers of tunnel states. framework based on a description of the underlying model. The MGF method has a noteworthy limitation, which it is hoped will be addressed in the future. It is not currently possible to include transitions based on wall time (except in the trivial case in which wall time is equal to sojourn time, i.e., for an initial state with no possibility of return) or for risks to compete from different starting times. These limitations make it challenging to include, for example, general mortality within a model. In certain situations it is, however, more important to capture sojourn time-dependent transitions, such as in advanced cancers.
The method also assumes independence of the TTE random variables in the specification. This does not mean, though, that the risks of different events must be treated as independent, as explained in Supplementary Appendix 8, because conditional independence can be leveraged in this regard. For example, the risk of a patient with a hematological cancer receiving a stem cell transplant and the risk of the same patient dying from other causes are related according to the age and frailty of the patient but may be independent across patients conditional on their age and frailty. In addition to future work to address the issues described above, we will also attempt to develop methods for incorporating flexible spline TTE distributions 23 and alternative competing risk specifications. 15, 16 
